Publication Title	Publication reference	URL of Dataset	Clinical Trial ID	Country	Country code	Study design	Total number of subjects	Ethnicity	Existent variables	Exclusion criteria	Inclusion criteria	Demographic	Clinical variables	Laboratory variables	Comorbidities	Drugs	Imaging	Endpoint	Type of data
COVID-19 Mortality Risk Assessment: An International Multi-Center Study	https://doi.org/10.1101/2020.07.07.20148304	NA	NA	USA	USA	Cross-sectional 	3927	NA	Demographic|Clinical|Laboratory|Comorbidities	NA	NA	Age|Sex	Heart Rate|Oxygen Saturation|Temperature	Alanine aminotransferase|Aspartate aminotransferase|Blood glucose|Blood urea nitrogen|C-Reactive protein|Creatinine|Hemoglobin|Corpuscular volume|Platelet count|Potassium|Prothrombin time|Sodium|White blood cell count	Cardiac dysrhythmias|Chronic kidney disease|Heart disease|Diabetes	NA	NA	NA	Structured
An artificial intelligence system for predicting the deterioration of COVID-19 patients in the emergency department	NA	NA	NA	USA	USA	Cross-sectional 	3661	NA	Demographic|Clinical|Laboratory|Imaging 	NA	Chest X-ray images linked to radiology reports & encounter information|Discharged patients|Chest X-rays collected prior to any adverse events|Non-intubated based on manual annotation	Age|BMI 	Heart Rate|Respiratory rate|Temperature|Systolic blood pressure|Diastolic blood pressure|Oxygen Saturation	Albumin|Alanine aminotransferase|Aspartate aminotransferase|Total bilirubin|Blood urea nitrogen|Calcium|Chloride|Creatinine|D-Dimer|Eosinophil count|Eosinophil percentage|Hematocrit|Lactate dehydrogenase|Lymphocyte percentage|Lymphocyte count|Platelet volume|Neutrophil count|Neutrophil percentage|Platelet count|Potassium|Procalcitonin|Total protein|Sodium|Troponin level 	NA	NA	X ray	NA	Mixed
Machine Learning to Predict Mortality and Critical Events in COVID-19 Positive 2 New York City Patients	https://doi.org/10.1101/2020.04.26.20073411	NA	NA	USA	USA	Cross-sectional 	3055	Non-Hispanic|Latino|Hispanic|Latino|Unknown	Demographic|Clinical|Laboratory|Comorbidities	NA	Inpatient|Age greater than 18|Positive result or RT-PCR SARS CoV-2 lab test|COVID 19 lab order less than equal to 48 hr after admit|Incubation time less than equal to 48 hr from admit|Death time after admit time	Age|Sex	Heart Rate|Pulse|Respiration Rate|Temperature|Systolic blood pressure|Diastolic blood pressure	Sodium|Potassium|Creatinine|Lactate|White blood cell count|Lymphocyte percentage|Hemoglobin|Red blood cell distribution width|Platelet count|Alanine aminotransferase|Aspartate aminotransferase|Albumin|Total bilirubin|Prothrombin time|Partial Prothrombin time|PCO2|pH|C-Reactive protein|Ferritin|D-Dimer|Creatinine phosphokinase|Lactate dehydrogenase|Troponin level 	Hypertension|Atrial fibrillation|Coronary artery disease|Heart failure|Stroke|Chronic kidney disease|Diabetes|Asthma|Chronic obstructive pulmonary disease|Cancer	NA	NA	NA	Structured
ICU and ventilator mortality among critically ill adults with COVID-19	https://doi.org/10.1101/2020.04.23.20076737	NA	NCT04280705	USA	USA	Observational	217	White|Black|Asian|Other|Unknown	Demographic|Laboratory|Drugs|Comorbidities	NA	NA	Age|Sex|BMI	ICU days|Hospital days|Ventilator days|Vassopressor days	D-Dimer|C-Reactive protein|PaO2/FiO2	Hypertension|Congestive heart failure|Coronary artery disease|Diabetes|Asthma|Chronic obstructive pulmonary disease|Chronic kidney disease/ end stage renal disease|	Hydroxychloroquine|Remdesivir 	NA	NA	NA
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study	https://doi.org/10.1016/S0140-6736(20)31189-2	NA	NA	USA	USA	Longitudinal	257	Black or African American|Hispanic or Latino|White|Asian|Other	Demographic|Clinical|Laboratory|Comorbidities|Drugs	NA	NA	Age|Sex|BMI 	Temperature|Heart Rate|Respiratory rate|Systolic blood pressure|Oxygen Saturation|Altered mental status	Lactate|Creatinine|Proteinuria|Urine protein concentration|White blood cell count|Lymphocyte count|Platelet count|Bilirubin|Aspartate aminotransferase|Alanine aminotransferase|Creatine kinase|Prothrombin time|Interleukin-6|High-sensitivity C-Reactive protein|Ferritin|D-Dimer|High-sensitivity Troponin|Procalcitonin 	Hypertension|Diabetes|Chronic Cardiac arrest (excluding hypertension)|Chronic kidney disease|Current or former smoker|Chronic obstructive pulmonary disease or interstitial Lung disease|Chronic neurological disease or dementia|Asthma|Active solid or haematological malignancy or dysplasia|Solid organ Transplantion recipient|HIV|Liver cirrhosis 	Hydroxychloroquine|Remdesivir 	NA	NA	Structured
Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series	https://doi.org/10.1136/bmj.m1996 	NA	NA	USA	USA	Observational	1000	Asian|Black or African American|Hispanic or Latino|Not specified|Other|White	Demographic|Comorbidities|Drugs	NA	NA	Age|Sex|BMI 	NA	NA	 Hypertension|Diabetes|Coronary artery disease|Congestive heart failure|Pulmonary disease|Asthma|Chronic obstructive pulmonary disease|Obstructive sleep apnea|Interstitial Lung disease|Renal disease|History of stroke|Active cancer|Transplantion history|Rheumatalogic disease|HIV|Viral hepatitis|Cirrhosis|Obesity 	ACEi|NSAIDs|Statinss|Diuretics|Inotropes|Vasopressors|Intravenous immunoglobulin|Steroidss|Hydroxychloroquine|Tocilizumab|Remdesivir|Lopinavir/Ritonavir|Azithromycin|Ceftriaxone|Doxycycline|Levofloxacin|Meropenem|Piperacillin/tazobactum|Vancomycin|Other antibiotics 	NA	NA	Unstructured
ACE-inhibitors and Angiotensin-2 Receptor Blockers are not associated with severe SARS- COVID19 infection in a multi-site UK acute Hospital Trust	https://doi.org/10.1002/ejhf.1924	NA	NA	UK	GBR	Interventional	12000	Caucasian|Black|Asian|Unknown|Mixed|Other	Demographic|Laboratory|Comorbidities|Drugs	NA	Admission of symptomatic patients	Age|Sex|BMI	NA	Systolic blood pressure|Diastolic blood pressure 	Hypertension|Diabetes|Heart failure|Ischaemic Heart Disease|Chronic obstructive pulmonary disease|Asthma|Chronic kidney disease|Previous stroke/TIA 	ACEi|ARB|Statins|Beta-blocker	NA	Death|Critical Care|Alive	NA
Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial	https://doi.org/10.1101/2020.03.21.20040691	NA	NCT04275245	China	CHN	Interventional	39	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Key to successful treatment of COVID-19: accuRate identification of severe risks and early intervention of disease progression	https://doi.org/10.1101/2020.04.06.20054890 	NA	NA	China	CHN	Observational	97	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Structured
Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study	https://doi.org/10.1016/j.jinf.2020.03.002	NA	NA	China	CHN	Interventional	33	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Structured
The Use of Adjuvant Therapy in Preventing Progression to Severe Pneumonia in Patients with Coronavirus Disease 2019: A Multicenter Data Analysis	https://doi.org/10.1101/2020.04.08.20057539	NA	NA	China	CHN	Observational	564	NA	Demographic|Laboratory|Comorbidities|Drugs|Imaging	Without available clinical or imaging data|Age less than 18 years	NA	Age|Sex 	NA	Hemoglobin|Platelet count|Neutrophil count|Leukocyte count|Alanine aminotransferase|Aspartate aminotransferase|Total bilirubin|Albumin|Blood urea nitrogen|Creatinine|Sodium|Potassium|Creatine kinase|Lactose dehydrogenase|D-Dimer|Procalcitonin|C-Reactive protein|Abnormal CT findings|Lung CT score 	Hypertension|Diabetes|Cardiovascular disease|Chronic obstructive pulmonary disease|Cerebrovascular disease|Chronic renal disease|Hepatitis B/C|Malignancy|Immunodeficiency 	Arbidol|Lopinavir/Ritonavir|Interferon-α	CT scan	Severe pneumonia	NA
Compassionate Use of Remdesivir for Patients with Severe Covid-19	https://doi.org/10.1056/NEJMoa2007016	NA	NA	USA|Europe|Japan	USA|JPN	Interventional	61	NA	Demographic|Laboratory|Comorbidities|Drugs|	NA	NA	Age|Sex 	NA	Alanine aminotransferase|Aspartate aminotransferase|Creatinine 	Any condition|Hypertension|Diabetes|Hyperlipidemia|Asthma	Remdesivir	NA	Death|Critical Care|Alive	Structured
Interleukin-6 signalling pathway inactivation with siltuximab in patients with COVID-19 respiratory failure: an observational cohort study	https://doi.org/10.1101/2020.04.01.20048561	NA	NCT04322188	Italy	ITA	Interventional	30	NA	Demographic|Laboratory|Comorbidities|Drugs|	NA	NA	Age|Sex|Height|Weight	NA	White blood cell count|Hemoglobin|Platelet count|Lymphocyte count|Monocyte count|Neutrophil count|Alanine aminotransferase|Aspartate aminotransferase|Creatinine|Procalcitonin|Lactate dehydrogenase|Interleukin-6|C-Reactive protein 	Hypertension|Diabetes|Cardiovascular disease|Malignancy|Cerebrovascular disease|Chronic kidney disease	Siltuximab	NA	Reduces morality associated with COVID 19 and respiratory failure	Structured
Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan, China	https://doi.org/10.1101/2020.03.25.20037721	NA	NA	China	CHN	Interventional	323	NA	Demographic|Laboratory|Comorbidities|Drugs|Imaging	NA	NA	Age|BMI|Sex|Temperature|Hypnotics|Smoking history|Drinking	NA	White blood cell count|Neutrophil count|Lymphocyte count|Platelet count|C-Reactive protein|Serum Amyloid A|Hypersensitive troponin|Prothrombin time|Creatine kinase|Lactate dehydrogenase|Alanine aminotransferase|Aspartate aminotransferase|Blood urea nitrogen|Creatinine|Glucose|RT-PCR	Cirrhosis|Hypertension|Diabetes|Malignancy|Cerebrovascular disease|Chronic obstructive pulmonary disease|Chronic kidney disease|Chronic liver disease|Cardiovascular and cerebrovascular diseases|Digestive system disease|Endocrine system disease|Nervous system disease|Respiratory disease	Oseltamivir|Ganciclovir|Arbidol|Kaletra|Interferon-α|Antibiotics|CorticoSteroids/glucocorticoid	CT scan	NA	Structured
An experimental trial of recombinant human interferon alpha nasal drops to prevent coronavirus disease 2019 in medical staff in an epidemic area	https://doi.org/10.1101/2020.04.11.20061473 	NA	NCT04320238	China	CHN	Interventional	2944	NA	Dermographic|Drugs	NA	Official members of Taihe Hospital Medical staff	Age|Sex 	NA	NA	NA	Interferon-α|Thymosin-α1	NA	NA	Structured
Heparin therapy improving hypoxia in COVID-19 patients - a case series	https://doi.org/10.1101/2020.04.15.20067017 	NA	NA	Brazil	BRA	Interventional	27	NA	Demographic|Laboratory|Comorbidities|Drugs	NA	NA	Age|Sex 	NA	D-Dimer|Lactate dehydrogenase|Platelet count|PaO2/FiO2 	Breast cancer|Atrial fibrillation|Obesity|Hypertension|Chronic obstructive pulmonary disease|Parkinson disease|Diabetes|Coronary heart disease|Hyperthyrodisim|Asthma|Cerebrovascular disease|Treated lymphoma|Tobacco dependence 	Heparin	NA	Discharged	NA
Experience with Hydroxychloroquine and Azithromycin in the COVID-19 Pandemic: Implications for QT Interval Monitoring	https://doi.org/10.1101/2020.04.22.20075671	NA	NA	USA	USA|JPN	Interventional	490	Hispanic|Non Hispanic|Unknown	Demographic|Comorbidities|Drugs|Imaging	NA	Inpatients with COVID 19|Inpatients with COVID 19 administered with AZ and/or HCQ|Patients with greater than 2 ECGs	Age|Sex|BMI	NA	NA	Heart failure|Hypertension|Diabetes|Chronic kidney disease|Chronic obstructive pulmonary disease	Azithromycin|Hydroxychloroquine	ECG	NA	Structured
Evaluation of antiviral therapies for coronavirus disease 2019 pneumonia in Shanghai, China	https://doi.org/10.1002/jmv.25893	NA	NA	China	CHN	Interventional	184	NA	Demographic|Laboratory|Drugs|Imaging	NA	NA	Age|Sex 	NA	Alanine aminotransferase|Aspartate aminotransferase|Leukocyte count|Neutrophil count|Lymphocyte count|Erythrocyte sedimentation rate	NA	Arbidol|Lopinavir/Ritonavir|Interferon-α|Darunavir	CT scan	NA	Structured
The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective clinical study	https://doi.org/10.1101/2020.03.28.20046144 	NA	chiCTR2000030700	China	CHN	Observational	42	NA	Demographic|Laboratory|Comorbidities|Drugs	Patients received glucocorticoids|Patients received immunepreparations|Patients with chronic infectious diseases|Patients had no cytokine test|Patients with liver and kidney insufficiency|Patients received Low Molecular Weight Heparin (LMWH) in the previous three months 	NA	Age|Sex 	NA	Respiratory rate|Pulse|Systolic blood pressure	Hypertension|Diabetes|Cardiovascular disease|Chronic obstructive Lung disease|Carcinoma|Chronic kidney disease	Arbidol|Recombinant human Interferon-α2B (aeresol inhalation)|Ribavirin|Lopinavir/Ritonavir|Traditional medicine|Heparin	NA	NA	Structured
No Clear Benefit to the Use of CorticoSteroids as Treatment in Adult Patients with Coronavirus Disease 2019 : A Retrospective Cohort Study	https://doi.org/10.1101/2020.04.21.20066258 	NA	NA	China	CHN	Interventional	115	NA	Demographic|Laboratory|Comorbidities|Drugs	NA	Patients diagnosed with COVID 19|Corticosteriod therapy	Age|Sex 	NA	White blood cell count|Lymphocyte count|Serum potassium|Creatinine|Lactate dehydrogenase|Serum Amyloid A|C-Reactive protein|Erythrocyte sedimentation rate|Creatine kinase|Albumin|D-Dimer|	Hypertension|Cardiovascular disease|Diabetes	Corticosteriod	NA	NA	Structured
Early, low-dose and short-term application of corticoSteroids treatment in patients with severe COVID-19 pneumonia: single-center experience from Wuhan, China	https://doi.org/10.1101/2020.03.06.20032342	NA	NA	China	CHN	Interventional	46	NA	Demographic|Clinical|Laboratory|Comorbidities|Drugs|Imaging	NA	NA	Age|Sex 	Temperature|Heart Rate|Systolic pressure|Diastolic blood pressure|Respiratory rate|SpO2 at rest	White blood cell count|Lymphocyte count|Neutrophil count|C-Reactive protein|Procalcitonin|Interleukin-2|Interleukin-4|Interleukin-6|Interleukin-10|Ferroprotein	Chronic Cardiac arrest|Chronic obstructive pulmonary disease|Cerebrovascular disease|Malignancy|Diabetes|Hypertension	Methylprednisolone 	CT scan	NA	Structured
Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19 	https://doi.org/10.1089/scd.2020.0080	NA	NA	USA	USA	Observational	24	NA	Demographic|Laboratory|Comorbidities|Drugs	NA	Age between 18 and 85 years|Positive result on SARS-CoV-2 polymerase chain reaction (PCR)|Presentation of fever and/or dyspnea for greater than 72 h|Overall clinicaldeterioration as evidenced by downtrending PaO2/FiO2 	Age|Sex|BMI|Weight|Height	NA	PaO2/FiO2	Hypertension|Hyperlipidemia	ExoFlo	NA	Recovered|Crticical Care	Structured
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study 	https://doi.org/10.1016/j.eng.2020.03.007	NA	ChiCTR2000029600	China		Observational	91	NA	Demographic|Laboratory|Comorbidities|Drugs|Imaging	NA	Age between 16 and 75 years old|Nasopharyngeal swabs samples tested positive for the novel coronavirus|Duration from disease onset to enrolment less than 7 days|Willing to take contraception during the study and within 7days after treatment|No difficulty in swalloing the pills. 	Age|Sex|BMI	NA	White blood cell count|Neutrophil count|Lymphocyte count|Alanine aminotransferase|Aspartate aminotransferase|Gamma glutamyl transpeptidase|C-Reactive protein|Interleukin-6|T lymphocyte count|CD4+ lymphocyte count|CD8+ lymphocyte count 	Myalgia|Diarrhoea	Favipiravir|Lopinavir/Ritonavir	CT scan	Adverse reactions like Diarrhoea|Vomiting|Nausea|Rash|Liver and Kidney injury|Others	Structured
Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19	NA	NA	NA	Italy	ITA	Interventional	63	NA	Demographic|Laboratory|Comorbidities|Drugs 	NA	Polymerase chain reaction confirmed|Pulmonary involvment, assessed either by oxygen saturation (SaO2) of less than 93% if they were breathing ambient air, or a ratio of partial pressure of oxygen (PaO2) to the fraction of inspired oxygen ( FiO2) of less than 300 mmHg|Markedly deranged proinflammatory and prothrombotic profile (at least 3 of the following): CRP greater than x 10 normal values, D-Dimer x 10 normal values, Lactate dehydrogenase x 2 the upper limits 	Age 	NA	D-Dimer|C-Reactive protein|Ferritin|Lymphocyte count|Interleukin-6	Hypertension|Diabetes|Heart disease|Chronic obstructive pulmonary disease	Tocilizumab	NA	 NA	NA
Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)	https://doi.org/10.1001/jamacardio.2020.1834 	NA	NA	USA	USA	Interventional	90	NA	Demographic|Laboratory|Comorbidities|Drugs 	NA	NA	Age|Sex|BMI	NA	Serum creatinine|White blood cell count|Absolute lymphocyte count|Maximum temperature on day of treatment initiation|C-Reactive protein|Creatine phosphokinase|D-Dimer|Lactate dehydrogenase|Ferritin 	Hypertension|Congestive heart failure|Diabetes|Coronary artery disease|Atrial fibrillation|Chronic obstructive pulmonary disease|Asthma	Hydroxychloroquine|Azithromycin	NA	NA	Structured
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy	https://doi.org/10.1016/j.autrev.2020.102568 	NA	NA	Italy	ITA	Interventional	100	NA	Demographic|Laboratory|Comorbidities|Drugs 	NA	NA	Age|Gender 	NA	White blood cell count|Neutrophil count|Lymphocyte count|Platelet count|Hemoglobin|C-Reactive protein|Interleukin-6|Ferritin|D-Dimer|Fibrinogen|Aspartate aminotransferase|Alanine aminotransferase|Lactate dehydrogenase|Triglycerides|Cholesterol|Creatine kinase|Troponin level	Arterial hypertension|Diabetes|Cardiovascular disease|Chronic kidney disease|Chronic obstructive pulmonary disease|Malignancy|Obesity 	Lopinavir/Ritonavir|Remdesivir|Azithromycin|Ceftriaxone|Piperacillin/tazobactum|Hydroxychloroquine|Dexamethasone	NA	NA	Structured
Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients	https://doi.org/10.1016/j.medmal.2020.05.001	NA	NA	France	FRA	Interventional	20	NA	Demographic|Clinical|Laboratory|Comorbidities|Drugs|Imaging	NA	NA	Age|Sex|BMI	quick-Sequential Organ Failure Assessment|Blood Pressure|Confusion or Glasglow scale|Respiratory rate|Oxygen Saturation 	Lymphocyte count|C-Reactive protein 	Hypertension|Diabetes|Chronic obstructive pulmonary disease|Immunosuppression|Malignancy	Tocilizumab	CT scan	Death|ICU admission|Discharge	Structured
Tocilizumab for Treatment of Severe COVID-19 Patients: Preliminary Results from SMAtteo COvid19 REgistry (SMACORE)	https://doi.org/10.3390/microorganisms8050695	NA	NA	Italy	ITA	Interventional	112	NA	Demographic|Laboratory|Comorbidities|Drugs	NA	NA	Sex|Age	NA	Lactate dehydrogenase|Lymphocyte count|Neutrophil count|Alanine aminotransferase|C-Reactive protein|Procalcitonin|Prolactonin|PaO2/FiO2	Past tumor|Hypertension|Heart disease|Diabetes|Obesity|Lung disease|Other comorbidities	Tocilizumab	NA	NA	Structured
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status	https://doi.org/10.1016/j.phrs.2020.104899	NA	NA	Italy	ITA	Interventional	50	NA	Demographic|Clinical|Laboratory|Comorbidities|Drugs 	NA	Male or non pregnant fenale aged greater than 18|SARS CoV-2 infection confirmed by postive RT PCR test|Had mechanical ventilation or oxygen saturation (SaO2)level of less than 94% in room air|National Early Warning Score (NEWS)2 greater than equal to 4 	Age|Sex 	Temperature 	FiO2|PaO2/FiO2|National Early Warning Score 2 (NEWS2)|White blood cell count|Lymphocyte count|Platelet count|Prothrombin time|D-Dimer|Alanine aminotransferase|Lactate dehydrogenase|C-Reactive protein|Serum creatinine 	Diabetes|Hypertension|Cancer|Obesity	Remdesivir	NA	Hospitalization|Death|Disharge	Structured
Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: outcomes in hospitalized COVID-19 patients	https://doi.org/10.1101/2020.05.02.20080036	NA	NA	USA	USA	Interventional	900	African American|White|Asian|Other|Multiracial|Unknown 	Demographic|Clinical|Laboratory|Comorbidities	NA	NA	Age|Sex|BMI	Respiratory rate|Oxygen Saturation|Pulse|Systolic blood pressure|Diastolic blood pressure|Temperature	White blood cell count|Absolute neutrophil count|Absolute lymphocyte count|Ferritin|D-Dimer|Troponin level|Creatine Phosphokinase|Procalcitonin|Creatinine|C-Reactive protein|	Hypertension|Hyperlipidemia|Coronary artery disease|Heart failure|Asthma|Diabetes|Malignancy|Transplantion|Chronic kidney disease 	NA	NA	NA	Structured
 Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy 	https://doi.org/10.1016/j.ejim.2020.05.011	NA	NA	Italy	ITA	Interventional	51	NA	Demographic|Clinical|Laboratory|Comorbidities|Drugs|Imaging	NA	Age greater than 18 years|Respiratory rate greater than equal to 30 per minutes|SpO2 less than 93% while breathing room air|PaO2/FiO2 less than 250 mmHg|Interleukin-6 plasma level greater than 40pg/mL 	Age|Sex 	Temperature|Charlson Comorbidity index	White blood cell count|Lymphocyte count|Neutrophil count|Lactate dehydrogenase|Aspartate aminotransferase|Alanine aminotransferase|C-Reactive protein|D-Dimer|Interleukin-6 	Cardiovascular disease|Hypertension|Diabetes|Chronic Lung disease|Cancer|Rheumatalogic disease|HIV|Chronic heapatitis C|Previous tuberculosis	Hydroxychloroquine|Lopinavir/Ritonavir|Remdesivir|Antibiotics|Tocilizumab	CT scan	Hospitalization|Death	Structured
 Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study 	https://doi.org/10.1016/j.ejim.2020.05.021	NA	NCT04318366	Italy	ITA	Interventional	65	NA	Demographic|Clinical|Laboratory|Comorbidities|Drugs|Imaging	NA	Diagnosis of COVID-19 confirmed upon reverse-transcriptase Polymerase Chain Reaction (RT-PCR) positivity for SARS-CoV-2 on nasopharyngeal swab|Hyper-inflammation defined as elevation in either C-Reactive protein (CRP, greater than equal to 100 mg/L, normal values less than 6 mg/L) or ferritin (greater than equal to 900 ng/mL, normal value less than 400 ng/mL), in the presence of increased lactate de-hydrogenase (LDH, greater than 220 U/L)|Severe respiratory involvement defined by typical radiological findings at chest X-ray and/or computed tomography (CT) scan, in the presence of an oxygen saturation (SaO2) less than equal to 92% while breathing ambient air or a ratio of the partial pressure of oxygen (PaO2) to the fraction of inspired oxygen (FiO2) (PaO2:FiO2) less than equal to 300 mmHg 	Age|Sex 	Temperature 	PaO2/FiO2|C-Reactive protein|Lactate dehydrogenase|Non invasive ventilation (NIV)	Arterial hypertension|Chronic obstructive pulmonary disease|Cancer|Coronary artery disease|Type-2 diabetes|Chronic kidney disease	Tocilizumab	CT scan	Hospitilization|Death|Discharge	Structured
Projecting COVID-19 disease severity in cancer patients using purposefully-designed machine learning	https://doi.org/10.1101/2020.08.23.20179838	NA	NA	USA	USA|JPN	Observational	354	NA	Demographic|Laboratory|Comorbidities 	NA	NA	Age|Sex|BMI	NA	Alanine aminotransferase|Activated partial thromboplastin time|Aspartate aminotransferase|Absolute lymphocyte count|Absolute neutrophil count|Absolute reticulocyte count|Albumin|Blood urea nitrogen|Total bilirubin|C-Reactive protein|Creatinine|D-Dimer|Erythrocyte sedimentation rate|Ferritin|Glucose|Hemoglobin|Interleukin-1 beta|Interleukin-10|Interleukin-6|Lactate dehydrogenase|PT|Platelet count|Procalcitonin|Troponin level|White blood cell count|ANC-ALC-ratio	Lymphoma cancer|Lung cancer|Leukemia cancer|Hypertension|Cardiac arrest|Chronic lower respiratory disease	NA	NA	NA	NA
Public health emergency SOLIDARITY trial of treatments for COVID-19 infection in hospitalized patients	https://doi.org/10.1101/2020.10.15.20209817	NA	ISRCTN83971151	NA	NA	Longitudinal	11266	NA	Laboratory|Clinical	NA	NA	NA	NA	NA	NA	NA	NA	Mortality	NA
Trial of Treatments for COVID-19 in Hospitalized Adults (DisCoVeRy)	https://doi.org/10.1101/2020.10.15.20209817	NA	NCT04315948	France	FRA	Longitudinal	3100	NA	Laboratory|Clinical	NA	NA	NA	NA	NA	NA	NA	NA	Mortality	NA
Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State	https://doi.org/10.1001/jama.2020.4326	NA	NA	USA	USA	Observational	21	NA	Clinical|Laboratory|Comorbidities|Imaging	NA	NA	NA	Temperature	White blood cell count|Absolute lymphocyte count|Hemoglobin|Platelet count|Sodium|Creatinine|Total bilirubin|Alkaline phosphatase|Alanine aminotransferase|Aspartate aminotransferase|Creatinine kinase|Venous lactate|Troponin level|Brain-type natriuretic peptide|Procalcitonin	Asthma|Chronic obstructive pulmonary disease|Congestive heart failure|Diabetes|Rheumatalogic disease|Obstructive sleep apnea|Chronic kidney disease|End stage renal failure|History of solid organ transplantion|Cirrhosis|Immunosuppression	NA	CT scan	Death|Remains critically ill and requires mechanicalventilation|Survived to transfer out of ICU|Length of follow-up for those who survived or remaincritically ill	NA
First 12 patients with coronavirus disease 2019 (COVID-19) in the United States	https://doi.org/10.1101/2020.03.09.20032896	NA	NA	USA	USA	Longitudinal	12	NA	Demographic|Laboratory|Comorbidities|Drugs|Imaging	NA	NA	Age|Sex 	NA	SpO2|Aspartate aminotransferase|Alanine aminotransferase|White blood cell count|Procalcitonin 	Cardiac arrest|Hypertension|Diabetes|Chronic Lung disease|High cholesterol|Fatty liver disease|Hepatitis B	Remdesivir	CT scan	Critical Care	Unstructured
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: an observational study	https://doi.org/10.1016/j.tmaid.2020.101663	NA	NA	France	FRA	Observational	80	NA	Demographic|Clinical|Comorbidities|Drugs|Imaging	NA	NA	Age|Sex 	Temperature 	NA	Cancer|Diabetes|Coronary artery disease|Hypertension|Chronic respiratory diseases|Obesity|Immunosuppressive treatment	Hydroxychloroquine|Azithromycin|Ceftriaxone 	CT scan	Death|Discharged|Hospitalization	NA
Covid-19 in Critically Ill Patients in the Seattle Region — Case Series	https://doi.org/10.1056/NEJMoa2004500	NA	NA	USA	USA	Observational	24	NA	Demographic|Clinical|Laboratory|Comorbidities|Drugs|Imaging	NA	NA	Age|Sex|BMI	Temperature|Heart Rate|Respiratory rate	White blood cell count|Lymphocyte count|Aspartate aminotransferase|Alanine aminotransferase|Lactate|Serum creatinine|Troponin level|Platelet count|Bilirubin|Creatine kinase	Asthma|Cancer|Chronic analysis|Chronic kidney disease|Chronic obstructive pulmonary disease|Diabetes|Hemorrhagic or ischemic stroke|Human immunodeficiency virus|Obstructive sleep apnea	Hydroxychloroquine|Lopinavir/Ritonavir 	CT scan	Death|Discharged|Hospitalization	NA
Level of Interleukin-6 predicts respiratory failure in hospitalized symptomatic COVID-19 patients	https://doi.org/10.1101/2020.04.01.20047381	NA	NA	Germany	DEU	Observational	40	NA	Demographic|Clinical|Laboratory|Comorbidities	NA	NA	Age 	Respiratory rate|Pulse 	Lymphoctye count|C-Reactive protein|Bilirubin|White blood cell count|Lactate dehydrogenase|Procalcitonin|Interleukin-6|Thrombocyte count|Troponin level|Creatinine|D-Dimer|Ferritin	Hypertension|Diabetes|Coronary artery disease|Chronic obstructive Lung disease	NA	NA	Critical Care	NA
No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection	https://doi.org/10.1016/j.medmal.2020.03.006	NA	NA	France	FRA	Observational	11	NA	Clincal|Comorbidities|Drugs|Viral load	NA	NA	Age	NA	NA	Obesity|Solid cancer|Hematalogical cancer|HIV 	Hydroxychloroquine|Azithromycin	NA	Death|Critical Care 	NA
First Case of 2019 Novel Coronavirus in the United States	https://doi.org/10.1056/NEJMoa2001191	NA	NA	USA	USA	Observational	1	NA	Demographic|Clinical|Laboratory|Drugs|Imaging|Epidemiological	NA	NA	Age|Sex 	Temperature|Blood Pressure|Pulse|Oxygen Saturation	White blood cell count|Red blood cell count|Absolute neutrophil count|Absolute lymphocyte count|Platelet count|Hemoglobin|Hematocrit|Sodium|Potassium|Chloride|Calcium|Carbon dioxide|Anion gap|Glucose|Blood urea nitrogen|Creatinine|Total protein|Albumin|Total bilirubin|Procalcitonin|Alanine aminotransferase|Aspartate aminotransferase|Alkaline phosphatase|Fibrinogen|Lactate dehydrogenase|Prothrombin time||Creatine kinase|Venous lactate	NA	Remdesivir|Vancomycin|Cefepime 	CT scan	NA	Unstructured
Epidemiological Characteristics of 2143 Pediatric Patients With 2019 Coronavirus Disease in China	https://doi.org/10.1542/peds.2020-0702	NA	NA	China	CHN	Observational	2143	NA	Demographic|Laboratory|Comorbidities|Imaging|Epidemiological|Severity of illness	NA	NA	Age|Gender 	NA	White blood cell count|Lymphocyte count|C-Reactive protein 	Fever|Respiratory symptoms|Digestive symptoms (e.g., vomiting, nausea and diarrhea)|Fatigue	NA	X ray	NA	NA
Machine Learning to Predict Mortality and Critical Events in COVID-19 Positive New York City Patients	https://doi.org/10.1101/2020.04.26.20073411	NA	NA	USA	USA	Observational	3055	Non-Hispanic|Latino|Hispanic|Latino|Unknown	Demographic|Clinical|Laboratory	NA	NA	Age|Sex	NA	NA	Hypertension|Atrial fibrillation|Coronary artery disease|Heart failure|Stroke|Chronic kidney disease|Diabetes|Asthma|Chronic obstructive pulmonary disease|Cancer	NA	NA	Mortality	Unstructured
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 CorticoSteroids Domain Randomized Clinical Trial	https://doi.org/10.1001/jama.2020.17022	NA	NCT02735707	Australia|Canada|France|Ireland|the Netherlands|New Zealand|the United Kingdom|and the United States.	GBR,USA	Longitudinal	614	White|Asian|Black|Mixed|Other	Demographic|Clinical	NA	NA	Age|Sex|BMI	NA	NA	NA	NA	NA	NA	Unstructured
GLUCOCOVID: A controlled trial of methylprednisolone in adults hospitalized with COVID-19 pneumonia	https://doi.org/10.1101/2020.06.17.20133579	NA	EudraCT number: 2020-001934-37	Spain	ESP	Longitudinal	85	NA	Demographic|Laboratory|Comorbidities|Drugs	NA	Symptom duration of atleast 7 days|Radiological evidence of Lung disease in chest X-ray or CT scan|ModeRate to severe disease with abnormal gas exchange: PaFi ( PaO2/FiO2) less than 300 or SAFI (SAO2/FiO2) less than 400 or atleast 2 criteria of the RESCIA-COVID Respiratory Severity Scale (BCRSS)|Laboratory parameters suggesting a hyper-inflammatory state: serum C-Reactive Protein (CRP) greater than 15 mg/dl, D-Dimer greater than 800 mg/dl, ferritin greater than 1000 mg/dl or Interleukin-6 levels greater than 20 pg/ml. 	Age|Sex 	NA	SAFI(SaO2/FiO2)|Creatinine|Lymphocyte count|Platelet count|C-Reactive protein|D-Dimer|Ferritin 	Hypertension|Cardiac arrest|Respiratory disease|Diabetes	Azithromycin|Hydroxychloroquine|Lopinavir/Ritonavir|Methylprednisolone|	NA	ICU admission|Non invasive ventilation|Mortality	NA
Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized Clinical study	https://doi.org/10.1016/j.jsbmb.2020.105751	NA	NCT04366908	Spain	ESP	Longitudinal	76	NA	Demographic|Laboratory|Comorbidities|Drugs	NA	NA	Age|Sex 	NA	PaO2/FiO2|C-Reactive protein|Lactate dehydrogenase|D-Dimer|Lymphocyte count|Ferritin|Interleukin-6	Lung disease|Chronic kidney disease|Diabetes|High blood pressure|Cardiovascular disease|Immunosuppressed & Transplantioned	Calcifediol|Hydroxychloroquine|Azithromycin	NA	ICU|Death|Discharged	Unstructured
Convalescent Plasma for COVID-19. A randomized clinical trial	https://doi.org/10.1101/2020.07.01.20139857	NA	NCT04342182	Netherlands	NLD	Longitudinal	86	NA	Demographic|Laboratory|Comorbidities|Drugs|Disease severity	NA	COVID-19 related symptoms for 10 days and had been admitted to the hospital for 2 days|Tested positive for anti-SARS-CoV-2 antibodies|Ig ratio was greater than 10 	Age|Sex 	NA	C-Reactive protein|Ferritin|Lactate dehydrogenase|Lymphocyte count|Bilirubin|WHO COVID-19 disease severity score|PRNT50 titer|Wantai ELISA positive	Diabetes|Hypertension|Cardiac arrest|Pulmonary disease|Cancer|Immunodeficiency|Chronic kidney disease|Liver cirrhosis	Chloroquine|Azithromycin|Lopinavir/Ritonavir|Tocilizumab|Anakinra	NA	Death|Hospitalizaiton	NA
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19. A Randomized Clinical Trial	https://doi.org/10.1001/jama.2020.10044	NA	ChiCTR2000029757	China	CHN	Longitudinal	103	NA	Demographic|Clinical|Laboratory|Viral load|Comorbidities	NA	Signed informed consent|Aged at least 18 years|COVID-19 diagnosisbased on polymerase chain reaction (PCR) testing|Posi-tive PCR result within 72 hours prior to randomization|Pneumonia confirmed by chest imaging|Clinical symp-toms meeting the definitions of severe or life-threatening COVID-19|Acceptance of random group assignment|Hospital admission|Willingness to participate in allnecessary research studies and be able to complete the study follow-up|No participation in other clinical trials,such as antiviral trials, during the study period 	Age|Sex	Temperature|Respiratory rate|Heart Rate|Systolic blood pressure 	White blood cell count|Neutrophil count|Platelet count|C-Reactive protein|Interleukin-6|Prothrombin time|Activated partial thromboplastin time|Thrombin time|Fibrinogen|D-Dimer|Alanine aminotransferase|Aspartate aminotransferase|Urea nitrogen|Serum creatinine	Hypertension|Cardiovascular disease|Cerebrovascular disease|Diabetes|Liver disease|Cancer|Kidney disease	NA	NA	Mortality	Structured
Core warming of coronavirus disease 2019 (COVID-19) patients undergoing mechanical ventilation: protocol for a randomized controlled pilot study	https://doi.org/10.1101/2020.04.03.20052001	NA	NCT04426344	USA	USA	Longitudinal	20	NA	Demographic|Clinical|Laboratory	NA	Patients above the age of 18 years old|Patients with a diagnosis of COVID-19 on mechanical ventilation|Patient maximum baseline temperature (within previous 12 hours) less than 38.3°C|Patients must have a surrogate or legally authorized representative able to understand and critically review the informed consent form	Age|Sex|Height|Weight	Temperature|Blood Pressure|Heart Rate|Respiration Rate 	Complete blood count (CBC)|Chemistry profiles|Liver function tests|C-Reactive protein|Ferritin|D-Dimer|Arterial blood gas for determination of PaO2	NA	NA	NA	NA	NA
Chest CT Scan of Hospitalized Patients with COVID-19: A Case-Control Study	https://doi.org/10.1101/2020.04.07.20056762	www.unmc.edu/publichealth/departments/biostatistics/jianghu-dong.html	NA	China	CHN	Observational	167	NA	Demographic|Clinical|Laboratory|Comorbidities|Imaging	NA	NA	Age|Sex	Temperature|Pulse|Respiratory rate|Blood Pressure	 C-Reactive protein|White blood cell count|Red blood cell count|Lymphocyte count|Hemoglobin|Plasma Prothrombin time determination|Thrombin time|Activated partial thromboplastin time|D-Dimer|Alanine aminotransferase|Urea nitrogen|Fibrinogen|Eosinophil count|Hematocrit 	High blood pressure|Diabetes|Cardiogenic diseases|Lung disease|Anaemia|Stroke|Kidney disease|Surgery|Liver disease	NA	CT scan	NA	NA
A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19 / Favipiravir for SARS-CoV-infected patients	https://doi.org/10.1128/AAC.01897-20	https://rctportal.niph.go.jp/en/detail?trial_id=jRCTs041190120	JPRN-jRCTs041190120	Japan	JPN	Interventional	86	NA	Proportion of subjects with clearance of SARS-CoV2 in nasopharyngeal swab by Day 6	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning	NA	https://clinicaltrials.gov/show/NCT04423991	NCT04423991	USA	USA	Interventional	290	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mortality	NA
COVID-19 Mortality Prediction Model	NA	https://clinicaltrials.gov/show/NCT04358510	NCT04358510	USA	USA|JPN	Observational	114	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mortality	NA
Arrhythmias in Patients With COVID-19	https://doi.org/10.1002/joa3.12405	https://clinicaltrials.gov/show/NCT04395664	NCT04395664	Denmark	DNK	Observational	1000	NA	In-hospital mortality during hospitalization and a confirmed COVID-19 diagnosis|Incident intensive care unit admission during hospitalization and a confirmed COVID-19 diagnosis|Incident pulmonary embolism during hospitalization and a confirmed COVID-19 diagnosis|Incident cardiac arrest during hospitalization and a confirmed COVID-19 diagnosis|Incident hypoxic respiratory failure during hospitalization and a confirmed COVID-19 diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	Mortality	NA
Explorative Study of the Association of Oropharyngeal Microbiota Profiles with SARS-CoV-2 Infection and COVID-19 disease	NA	http://www.drks.de/DRKS00021424	DRKS00021424	Germany	DEU	Observational	360	NA	Omics (oropharyngeal mikrobiota)	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Incidence and risk factors for acute kidney injury in COVID-19	https://doi.org/10.1016/j.mayocpiqo.2020.07.003	http://www.drks.de/DRKS00021658	DRKS00021658	Germany	DEU	Observational	100	White|African American|Hispanic|Other	Demographic|Clinical|Laboratory|Comorbidities	NA	NA	Age|Sex|BMI	NA	NA	Hypertension|Diabetes|Hyperlipidemia|Cardiac arrest|Chronic kidney disease|Chronic obstructive pulmonary disease|Stroke or dementia|Smoking|Malignancy|Obesity	NA	NA	NA	NA
START (Siddha Treatment Accelerating Recovery from SARS-CoV-2 Test) trial of Siddha treatment for patients with novel coronavirus infectious disease (COVID-19)	NA	http://isrctn.com/ISRCTN13311119	ISRCTN13311119	India	IND	Interventional	116	NA	Laboratory|Viral load	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Investigating the microorganisms found in the mouths of SARS-Cov-2 positive patients	NA	http://isrctn.com/ISRCTN87832712	ISRCTN87832712	Italy	ITA	Observational	> 20	NA	Oral microbiome|Cytokine|Viral load	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Long-term follow up of adults hospitalised with COVID-19	NA	http://isrctn.com/ISRCTN10980107	ISRCTN10980107	UK	GBR	Observational	10000	NA	Laboratory|Clinical|Questionnaires|Viral load|Biosampling for omics	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Zurich Coronavirus Cohort: an observational study to determine long-term clinical outcomes and immune responses after coronavirus infection (COVID-19), assess the influence of virus genetics, and examine the spread of the coronavirus in the population of the Canton of Zurich, Switzerland	NA	http://isrctn.com/ISRCTN14990068	ISRCTN14990068	Switzerland	CHE	Observational	3200	NA	Viral load|Hospital stay|Questionnaries	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
The symptoms, virology and immunity of COVID in healthcare workers	NA	http://www.isrctn.com/ISRCTN44324934	ISRCTN44324934	UK	GBR	Longitudinal 	135	NA	Viral load|Serum antibody level	NA	Any patient-facing clinical staff member working regularly in the Children’s Emergency Department (CED) of Bristol Royal Hospital for Children, including doctors, nurses and healthcare assistants	Age|Sex 	NA	NA	NA	NA	NA	NA	NA
Investigating blood clotting changes in patients with COVID-19 	NA	http://www.isrctn.com/ISRCTN64783542	ISRCTN64783542	UK	GBR	Longitudinal 	1000	NA	Demographic|Coagulation parameters|Blood clotting capability|Clinical|Laboratory	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Development of a risk prediction model for people with diabetes and COVID-19 in Scotland	NA	https://www.isrctn.com/ISRCTN45562523 	ISRCTN45562523	UK	GBR	Observational	5782649	NA	Viral load|Hospital stay|ICD10 codes for hospital discharge diagnoses|CCU	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Anakinra in hospitalized patients with severe COVID-19 pneumonia requiring oxygen therapy: results of a prospective, open-label, interventional study / Effect of the anti-inflammatory test drug anakinra in patients with coronavirus (COVID-19) requiring oxygen support	https://doi.org/10.1016/j.ijid.2020.11.149	https://www.isrctn.com/ISRCTN74727214	ISRCTN74727214	Oman	OMN	Retrospective	75	NA	Inflammatory biomarker|IMV	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Adaptive COVID-19 treatment trial in the EU & UK	NA	https://www.isrctn.com/ISRCTN13035264	ISRCTN13035264	UK	GBR	Interventional	1063	Hispanic or Latino|Not Hispanic or Latino|Unknown or Not Reported	Demographic|Laboratory|Drugs|Comorbidities|Serious adverse events (SAEs)|Clinical	Alanine transaminase (ALT) or Aspartate transaminase (AST) greater than 5 times the upper limit of normal|Estimated glomerular filtration rate (eGFR) less than 30 ml/min (including patients receiving hemodialysis or hemofiltration)|Pregnancy or breast feeding|Anticipated discharge from the hospital or transfer to another hospital which is not a study site within 72 hours|Allergy to any study medication	NA	Age|Sex 	NA	Alanine transaminase|Aspartate transaminase|Creatinine|Glucose|Hemoglobin|Platelet count|Prothrombin time|Total bilirubin|White blood cell count|Neutrophil count|Lymphocyte count|Monocyte count|Basophil count|Eosinophil count	Coagulopathy|Febrile neutropenia|Anaemia|Cardiac arrest|Atrial fibrillation|Cardio-respiratory arrest|Myocardial infarction|Supraventricular tachycardia|Ventricular tachycardia|Acute myocardial infarction|Cardiac failure|Cardiogenic shock|Acute coronary syndrome|Arrhythmia|Palpitations|Pulseless electrical activity|Ventricular fibrillation|Cardiac tamponade 	 Remdesivir	NA	Death|Hospitalizaiton	NA
Does ivermectin cure and/or prevent COVID-19?	NA	https://www.isrctn.com/ISRCTN40302986	ISRCTN40302986	Nigeria	NGA	Double-blind clinical trial	45	NA	Viral load|Clinical 	NA	NA	NA	NA	NA	NA	NA	NA	Mortality	NA
ADAPT - COVID-19 Study - Characterising pathophysiological, immunological and clinical outcomes relating to COVID-19 infection in the patient population of St Vincent’s Hospital Sydney.	NA	http://www.anzctr.org.au/TrialSearch.aspx	ACTRN12620000554965	Australia	AUS	Longitudinal	300	NA	Immunology|Lung and gut microbiome	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
COVID-19 Critical Care Consortium Observational Study Incorporating the Extracorporeal Membrane Oxygenation for 2019 Novel Coronavirus Acute Respiratory Disease (ECMOCARD)	NA	http://www.anzctr.org.au/TrialSearch.aspx	ACTRN12620000421932	Australia	AUS	Longitudinal	10000	NA	Clinical|ICU	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research	NA	https://clinicaltrials.gov/show/NCT04327804	NCT04327804	USA	USA	Longitudinal	120	NA	Viral load	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Longitudinal Population-based Observational Study of COVID-19 in the UK Population (COVIDENCE UK)	NA	https://clinicaltrials.gov/show/NCT04330599	NCT04330599	UK	GBR	Longitudinal	12000	NA	Diverse clinical and social end points	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Cardiac imaging phenotype in patients with coronavirus disease 2019 (COVID-19): results of the cocarde study / Myocardial Involvement of Severe Acute Respiratory Syndrome-Cov-2 (Covid19) Infected Patients (COCARDE)	https://doi.org/10.1007/s10554-020-02010-4 	https://clinicaltrials.gov/show/NCT04358952	NCT04358952	France	FRA	Longitudinal	50	NA	Demographic|Clinical|Laboratory|Comorbidities|Viral load|Electrocardiogram|Inflammatory parameter	NA	NA	Age|Sex|BMI	Systolic Arterial pressure|Diastolic Arterial pressure|Heart Rate	High-sensitivity Troponin|NT-proBNP|Creatinine|Leukocyte count|Lymphocyte count|Platelet count|Hemoglobin|C-Reactive protein|Alanine aminotransferase|Aspartate aminotransferase|Estimated glomerular filtration rate	Hypertension|Diabetes|Hypercholesterolemia|Obesity|Cerebrovascular disease|Chronic renal failure|Chronic obstructive pulmonary disease|Sleep disordered breathing	NA	NA	NA	NA
COVID-19 Immune Repertoire Sequencing (IMSEQ)	NA	https://clinicaltrials.gov/show/NCT04368143 	NCT04368143 	Belgium	BEL	Longitudinal	100	NA	B and T cell repertoires	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC)	NA	https://clinicaltrials.gov/show/NCT04378777	NCT04378777	USA	USA	Longitudinal	2000	NA	Clinical|ICU|Biosampling	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Predictive Immune Biomarkers for COVID-19 Pathogenesis (COVIDBioToul)	NA	https://clinicaltrials.gov/show/NCT04385108	NCT04385108	France	FRA	Longitudinal	170	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Longitudinal COVID-19 Cohort Study	NA	https://clinicaltrials.gov/show/NCT04393155	NCT04393155	USA	USA	Longitudinal	225	NA	Immunology|FVC|FEV1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study / COVID-19 and Diabetes Outcomes (CORONADO)	https://doi.org/10.1007/s00125-020-05180-x	https://clinicaltrials.gov/show/NCT04324736	NCT04324736	France	FRA	Observational	1317	Europid|Middle East North Africa|African or Caribbean|Asian	Demographic|Laboratory|Comorbidities	NA	Hospitalisation in a dedicated COVID-19 unit with COVID-19 diagnosis confirmed biologically (by SARS-CoV-2 PCR test) and/or clinical-ly/radiologically (i.e. as ground-glass opacity and/orcrazy paving on chest computed tomography [CT]scan)|Personal history of diabetes or newly diag-nosed diabetes on admission 	Age|Sex|BMI	NA	Positive SARS-CoV-2 PCR|Admission plasma glucose|Plasma creatinine|Estimated glomerular filtration rate|Alanine aminotransferase|Aspartate aminotransferase|Glutamyl transferase|Hemoglobin|White blood cell count|Lymphocyte count|Platelet count|D-Dimer|C-Reactive protein|Lactate dehydrogenase|Fibrinogen|Creatinine phosphokinase 	Heart failure|Liver cirrhosis|Cancer|Chronic obstructive pulmonary disease|Obstructive sleep apnea|Organ failure|End stage renal failure	NA	CT scan	Death|Discharged	NA
ELISA - LübEcker longitudinal study on Infections with SARS-CoV-2 (COVID-19)	NA	http://www.drks.de/DRKS00023418	DRKS00023418	Germany	DEU	Longitudinal	3000	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Coronavirus (COVID-19) antibody response in healthcare staff	NA	http://isrctn.com/ISRCTN15634328	ISRCTN15634328	UK	GBR	Longitudinal	2000	NA	Antibody titer	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Profile of hospitalized patients with Covid-19 and repercussions of physiotherapy	https://doi.org/10.1016/j.jphys.2020.03.011	http://www.ensaiosclinicos.gov.br/rg/RBR-2f9k8p/	RBR-2f9k8p	Brazil	BRA	Longitudinal	2000	NA	Clinical	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Novel Coronavirus infection among health workers	NA	https://ensaiosclinicos.gov.br/rg/RBR-7nky44/	RBR-7nky44 	Brazil	BRA	Observational	703	NA	Clinical	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Beat COVID-19 - Observational Trial (JUPITER)	NA	https://clinicaltrials.gov/show/NCT04337762	NCT04337762	USA	USA	Observational	100000	NA	Clinical	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Antibodies to SARS-CoV-2 and risk of future sickness / Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare	https://doi.org/10.1038/s41598-021-84356-w	https://clinicaltrials.gov/show/NCT04411576	NCT04411576	Sweden	SWE	Observational	40000	NA	Demographic|Sick leave records|Clinical|Sequencing	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Baricitinib restrains the immune dysregulation in severe COVID-19 patients. / Evaluation of Immune Response in COVID-19 Patients (IMMUNOVID)	https://doi.org/10.1172/JCI141772	https://clinicaltrials.gov/show/NCT04355611	NCT04438629	Italy	ITA	Observational	80	NA	Immunology|Pao2/FiO2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Beyond COVID-19: do MS/NMO-SD patients treated with anti-CD20 therapies develop SARS-CoV2 antibodies ? / Epidemiological Characteristics of COVID-19 in Patients With MS or NMO (COVISEP)	https://doi.org/10.1016/j.msard.2020.102482	https://clinicaltrials.gov/show/NCT04355611	NCT04355611	France	FRA	Observational	2000	NA	7-point severity scale at Nadir	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Covid-19 serology in nephrology health care workers / Study to Determine the Immunization Status Among Nephrological Health Care Personnel Against SARS-CoV-2 in a Single Center Over the Course of 12 Months During the Worldwide COVID-19 Pandemic. (CONEC)	NA	https://clinicaltrials.gov/show/NCT04347694	NCT04347694	Austria	AUT	Observational	400	NA	Demographic|Laboratory|Comorbidities|COVID-19 diagnostic	NA	NA	Age|Sex|BMI	NA	IgG|IgA|IgM	Hypertension|Diabetes|Cornoary artery disease|Chronic kidney disease|Lung disease|Autoimmune disease|Cancer	NA	NA	NA	NA
Development and validation of a risk factor-based system to predict short-term survival in adult hospitalized patients with COVID-19: a multicenter, retrospective, cohort study / Study for epidemiology, diagnosis and treatment of novel coronavirus pneumonia (COVID-19)	https://doi.org/10.1186/s13054-020-03123-x		ChiCTR2000029770	China	CHN	Observational	828	NA	Demographic|Clinical|Imaging|Laboratory|Medical records 	NA	NA	NA	NA	NA	NA	NA	NA	Mortality	NA
Disease-associated antibody phenotypes and probabilistic seroprevalence estimates during the emergence of SARS-CoV-2	https://doi.org/10.1101/2020.07.17.20155937			Sweden	SWE	Observational	105	NA	Demographic|Laboratory|COVID-19 diagnostic	NA	NA	Age|Sex 	NA	Interleukin-6|PSV ID50|IgG (Spike)|IgG (Receptor binding domain)|IgM (Spike)|IgM (Receptor binding domain)|IgA (Spike)|IgA (Receptor binding domain)	NA	NA	NA	NA	NA
Effects of Tocilizumab on Mortality in Hospitalized Patients with COVID-19: A Multicenter Cohort Study	https://doi.org/10.1101/2020.06.08.20125245			Spain	ESP	Observational	1229	NA	Demographic|Clinical|Laboratory|Comorbidities|Drugs	NA	Heightened high CRP levels	Age|Sex	Heart Rate|Systolic blood pressure|Temperature|Oxygen Saturation	Absolute lymphocyte count|Absolute neutrophil count|Lactate dehydrogenase|Alanine aminotransferase|Urea|C-Reactive protein|D-Dimer|Interleukin-6 	Hypertension|Diabetes|Congestive heart failure|Coronary artery disease|Chronic kidney disease|Lung disease	Tocilizumab	NA	ICU|Mortality	NA
Efficacy of Tocilizumab on Patients With COVID-19	https://doi.org/10.1056/NEJMoa2028836	https://clinicaltrials.gov/show/NCT04356937	NCT04356937	USA	USA	Interventional	243	NA	Clinical|ICU|Ordinal scale scores 	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Efficacy of corticoSteroidss in non-intensive care unit patients with COVID-19 pneumonia from the New York Metropolitan region	https://doi.org/10.1101/2020.07.02.20145565			USA	USA	Observational	205	Hispanic|Non-Hispanic African American|Non-Hispanic White|Others	Demographic|Laboratory|Comorbidities|Drugs|ICU transfer|Intubation|In-hospital mortality 	NA	Age greater than 18years old|Confirmed cases of SARS-CoV-2 by PCR method|Admitted in general wards|PaO2/FiO2 less than 300 if Arterial blood gas was available or SpO2/Fio2(SF)ratio kess than 440|Bilateral infiltRate on chest imaging validated by radiology staff 	Age|Sex|BMI	NA	PaO2/FiO2|SpO2/FiO2|Sequential Organ Failure Assessment|Hemoglobin|White blood cell count|Absolute lymphocyte count|Platelet count|Globular filtration rate|Aspartate aminotransferase|Alanine aminotransferase|Procalcitonin|Ferritin|Lactate dehydrogenase|D-Dimer|C-Reactive protein|Interleukin-6 	Obesity|Hypertension|Diabetes|Chronic Lung disease|Cancer|Coronary artery disease|Heart failure	Corticosteriod|Hydroxychloroquine|Tocilizumab|Enoxaparin therapeutic dose	NA	NA	NA
Multi-site Adaptive Trials for COVID-19	NA		NCT04370262	USA	USA	Interventional	942	NA	Clinical|7-point ordinal scale	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study / The Prone Position in Covid-19 Affected Patients (PRON-COVID)	https://doi.org/10.1016/S2213-2600(20)30268-X	https://clinicaltrials.gov/show/NCT04365959	NCT04365959	Italy	ITA	Observational	56	NA	Demographic|Laboratory|Comorbidities|Anthropometrics|Arterial blood gas|Ventilation parameters|Oxygenation	NA	NA	Age|Sex|BMI	NA	Sodium|Potassium|Chlorine|Creatinine|Urea|White blood cell count|Platelet count|Hemoglobin|Hematocrit|Bilirubin|C-Reactive protein|Procalcitonin|Lactate dehydrogenase|Aspartate aminotransferase|Alanine aminotransferase|Activated partial thromboplastin time|D-Dimer|pH|PaO2|PaCO2|SaO2 	Previous myocardial infarction|Congestive heart failure|Hypertension|Vascular disease|Chronic bronchopulmonary disease|Gastric or liver disease|Diabetes|Chronic kidney disease|Solid malignancy	NA	NA	Death|Hospitalizaiton	NA
Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome. / French COVID Cohort (FrenchCOVID)	https://doi.org/10.1007/s10875-020-00839-x	https://clinicaltrials.gov/show/NCT04365959	NCT04262921	France	FRA	Observational	5000	NA	Clinical|Biological|Radiological and virological assessments|Immunology	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Immunological and inflammatory profiles in mild and severe cases of COVID-19	https://doi.org/10.1038/s41467-020-17240-2			China	CHN	Observational	41	NA	Demographic|Clinical|Laboratory|Comorbidities	NA	NA	Age|Sex 	Temperature 	Leukocyte count|Neutrophil count|Lymphocyte count|Platelet count|Hemoglobin|Activated partial thromboplastin time|Prothrombin time|Prothrombin time|D-Dimer|Albumin|Alanine aminotransferase|Aspartate aminotransferase|Total bilirubin|Serum creatinine|Lactate dehydrogenase|Interleukin-6|C-Reactive protein|Procalcitonin|Erythrocyte sedimentation rate|Serum ferritin 	Hypertension|Diabetes|Malignancy|Chronic liver disease	NA	NA	NA	NA
A Trial of Ciclesonide in Adults With Mild-to-modeRate COVID-19	https://doi.org/10.1016/j.cmet.2020.06.015	https://clinicaltrials.gov/show/NCT04330586	NCT04330586	Korea	KOR	Interventional	94	NA	Clinical|Viral load|ICU	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
In-hospital Use of Statinss is Associated with a Reduced Risk of Mortality among Individuals with COVID-19	https://doi.org/10.1016/j.cmet.2020.06.015			China	CHN	Observational	13981	NA	Demographics|Clinical|ICU	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Statins THERAPY AND COVID-19 INFECTION (STACOV)	NA	https://clinicaltrials.gov/show/NCT04407273	NCT04407273	Spain	ESP	Observational	1200	NA	WHO SARS-CoV-2 scale of severity (9 steps)	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Large-scale Multi-omic Analysis of COVID-19 Severity	https://doi.org/10.1016/j.cels.2020.10.003	https://covid-omics.app 		USA	USA	Observational	128	White|Black|Asian|Hispanic|Other 	Demographic|Clinical|Laboratory|RNA-seq|Drugs|High-resolution mass spectrometry|WHO ordinal score at 28 days|HFD-45	NA	NA	Age|Sex|BMI	NA	Ferritin|C-Reactive protein|D-Dimer|Procalcitonin|Lactate|Fibrinogen|Albumin|White blood cell count|Hemoglobin|Corpuscular volume|Platelet count|Neutrophil count|Lymphocyte count|Monocyte count|Eosinophil count|PaO2/FiO2|Positive-end expiratory pressure|Inspiratory plateau	NA	Hydroxychloroquine|Replacement therapy (pre-enrollment)|Antibiotics|Antiviral|IL6 - antagoinist|Convalescent plasma|Steroids|Therapeutic anticoagulation	NA	NA	NA
Prognostic factors associated with mortality risk and disease progression in 639 critically ill patients with COVID-19 in Europe: Initial report of the international RISC-19-ICU prospective observational cohort / The RIsk Stratification in COVID-19 Patients in the ICU Registry (RISC-19-ICU)	https://doi.org/10.1016/j.eclinm.2020.100449	https://www.risc-19-icu.net	NCT04357275	Switzerland	CHE	Observational	10000	NA	ICU 	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Retrospective Observational Study of Brain Magnetic Resonance Imaging Findings in Patients with Acute SARS-CoV-2 Infection and Neurological Manifestations / Cohort of Patients With Covid-19 Presenting Neurological or Psychiatric Disorders (CoCo-Neurosciences) (CoCo-Neuro)	https://doi.org/10.1148/radiol.2020202422	https://clinicaltrials.gov/show/NCT04362930	NCT04362930	France	FRA	Observational	2000	NA	Demographic|ICU|Brain MRI|	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Timing COVID-19 - Synchronization of longitudinal patient data to the underlying disease progression using CRP as a temporal marker	https://doi.org/10.1101/2020.06.11.20128041	https://www.risc-19-icu.net	NCT04357275 (partly)	Switzerland	CHE	Observational	28	NA	Demographic|Comorbidities|ICU|Laboratory	NA	NA	Age|Sex|BMI	NA	NA	Coronary artery disease|Chronic Heart failure|Peripheral artery disease|Arterial hypertension|Diabetes 	NA	NA	NA	NA
Persistent hypermetabolism and longitudinal energy expenditure in critically ill patients with COVID-19. / Longitudinal Energy Expenditure and Metabolic Effects in Patients With COVID-19 (LEEP-COVID)	https://doi.org/10.1186/s13054-020-03286-7	https://clinicaltrials.gov/show/NCT04350073	NCT04350073	USA	USA	Observational	120	NA	ICU|Laboratory|Metabolic parameter (e.g.|pREE)	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Increased Risk of SARS-CoronaVirus-2 (SARS-CoV-2) Infection Associated With Endoscopy (DECORE Study) (DECORE)	NA	https://clinicaltrials.gov/ct2/show/NCT04401033	NCT04401033	Spain	ESP	Observational	450	NA	Clinical|Laboratory	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Diagnostic Value of Patient - Reported and Clinically Verified Olfactory Disorders (COVID-19) (COVID-OLFA)	https://doi.org/10.1001/jamaoto.2020.5074	https://clinicaltrials.gov/show/NCT04407494	NCT04407494	France	FRA	Observational	809	NA	Diagnostic values of anosmia and ageusia for COVID-19|Diagnostic values of CODA (Clinical Olfactory dysfunction Assessment)	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Classification of COVID-19 Infection in Posteroanterior Chest X-rays	NA	https://clinicaltrials.gov/ct2/show/NCT04358536	NCT04358536	USA	USA	Observational	230	NA	Clinical	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
The Use of Oxygen Hoods as Compared to Conventional High-flow Oxygen Delivery Systems, the Effects on Oxygenation, Mechanical Ventilation and Mortality Rates in Hypoxic Patients With COVID-19. A Prospective Controlled Cohort Study.	https://doi.org/10.1016/j.rmed.2021.106312	https://clinicaltrials.gov/show/NCT04407260	NCT04407260	USA	USA	Observational	136	NA	Oxygen Saturation||Intubation/mechanical Ventilation	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Experience of an Emergency Intensive Care Unit During COVID-19 Pandemic	NA	https://clinicaltrials.gov/show/NCT04480060	NCT04480060	Turkey	TUR	Observational	100000	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mortality	NA
Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19	https://doi.org/10.1007/s11239-020-02235-z	https://clinicaltrials.gov/show/NCT04374617	NCT04374617	Spain	ESP	Observational	230	NA	NA 	NA	NA	NA	NA	NA	NA	NA	NA	Venous thromboembolisms|Mortality	NA
COVID-19: A Prevalence Study of Two ART Centres After the Pandemic Lockdown in the USA (COVID-19 Free Clinics)	NA	https://clinicaltrials.gov/show/NCT04466644	NCT04466644	USA	USA	Observational	340	NA	Prevalence of contagiousness in asymptomatic individuals by PCR with nasopharyngeal swabs|Ratio of asymptomatic immunized (IgG) population	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Prognosis in Pregnant With COVID-19	NA	https://clinicaltrials.gov/show/NCT04409249	NCT04409249	Turkey	TUR	Observational	155	NA	Factors affecting prognosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Clinical and Radiomic Model of COVID-19	https://doi.org/10.1111/aas.13694	https://clinicaltrials.gov/show/NCT04337502	NCT04337502	Netherlands	NLD	Observational	300	NA	Predictive performance	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Possible Predictors of Mortality Based on COVID-19 for Patients Under 50 Years Old: A Multi-Center Experience of Istanbul	NA	https://clinicaltrials.gov/ct2/show/NCT04479137	NCT04479137	Turkey	TUR	Observational	5000	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mortality	NA
Respiratory Mechanics and Gas Exchange in Patients With COVID-19 and Hypoxemic Acute Respiratory Failure (COVID-VENT)	NA	https://clinicaltrials.gov/ct2/show/NCT04445961	NCT04445961	Russia	RUS	Observational	117	 	Optimum positive end-expiratory pressure	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Seroprevalence of SARS-Cov-2 in the Setting of a Non-dedicated COVID-19 Hospital in a Low CoV-2 Incidence Area: Implications for Surgery	https://doi.org/10.1016/j.amsu.2020.11.006	https://clinicaltrials.gov/ct2/show/NCT04480580	NCT04480580	Italy	ITA	Observational	100	NA	Demographic|Imaging|Seroprevalence of SARS-CoV-2	NA	NA	Age|Sex 	NA	NA	NA	NA	CT scan	NA	NA
COVID-19 Serology Screening and Strict Protocol in the Endoscopy Unit	NA	https://clinicaltrials.gov/ct2/show/NCT04374123	NCT04374123	Ecuador	ECU	Observational	111	NA	COVID-19 infection in the staff documented via PCR|serum levels of IgG and IgM against COVID-19|Endoscopic records of patients treated during the COVID-19 protocol	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Determinants of COVID-19 Pneumonia (MC-19) (MC-19)	NA	https://clinicaltrials.gov/ct2/show/NCT04387799	NCT04387799	Italy	ITA	Observational	520	NA	Serology|Efficacy of CT scan and Serology|Efficacy of different pharmaceutical treatments against Covid-19	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Risk Factors and Computed Tomography Findings in COVID-19.	NA	https://clinicaltrials.gov/ct2/show/NCT04577105	NCT04577105	Mexico	MEX	Observational	233	NA	Level of suspicion of SARS-CoV2 infection	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Prognosis of Coronavirus Disease 2019 (COVID-19) Patients Receiving Receiving Antihypertensives	NA	https://clinicaltrials.gov/ct2/show/NCT04357535	NCT04357535	Saudi arabia	SAU	Observational	314	NA	Severity of COVID-19 Infection|PaO2/FiO2 	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients	NA	https://ClinicalTrials.gov/show/NCT04412304	NCT04412304	Sweden	SWE	Observational	166	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Hyponatremia|Mortality|Hyponatremia|ICU 	NA
Anti Infective Agents Impact in COVID-19 Pneumonia	NA	https://ClinicalTrials.gov/show/NCT04453501	NCT04453501	France	FRA	Observational	132	NA	Risk factor measurements	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
COVID-19 Disease Duration and GIT Manifestations. A New Disease Severity Classification. An Egyptian Experience	NA	https://ClinicalTrials.gov/show/NCT04554979	NCT04554979	Egypt	EGY	Observational	199	NA	GIT manifestations|Disease spectrum and duration 	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Early Short-Course CorticoSteroidss in COVID-19 	https://doi.org/10.1093/cid/ciaa601	https://ClinicalTrials.gov/show/NCT04374071	NCT04374071	USA	USA	Observational	250	NA	Transfer to Intensive care unit (ICU)|Need for Mechanical Ventilation||Development and Severity of ARDS|Length of hospital stay (LOS)	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19)	NA	https://ClinicalTrials.gov/show/NCT04393428	NCT04393428	France	FRA	Observational	100	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Characteristics and Outcomes of Patients Admitted to Swedish Intensive Care Units for COVID-19	https://doi.org/10.1101/2020.08.06.20169599	https://ClinicalTrials.gov/show/NCT04462393	NCT04462393	Sweden	SWE	Observational	1563	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mortality|ICU 	NA
Evolution of COVID-19 in Anticoagulated or Antiaggregated Patients (CORONA Study)	NA	https://ClinicalTrials.gov/show/NCT04518735	NCT04518735	Spain	ESP	Observational	1707	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mortality|Transfer to the Intensive Care Unit (ICU)|Thromboembolic complications|Major bleeding complications	NA
The Development of Pancreatic Injury in the Course of Severe Acute Respiratory Syndrome Coronavirus 2 Infection	NA	https://ClinicalTrials.gov/show/NCT04433754	NCT04433754	Turkey	TUR	Observational	500	NA	NA	NA	NA	NA	NA	C-Reactive protein|D-Dimer 	Fever|Dyspnea 	NA	NA	NA	NA
The Impact of COVID-19 Pandemic on Critical Limb Threatening Ischemia and Emergency Vascular Practice	NA	https://ClinicalTrials.gov/show/NCT04452682	NCT04452682	Egypt	EGY	Observational	998	NA	ICU 	NA	NA	NA	NA	NA	NA	NA	NA	Mortality	NA
COVID-19 in the Swedish ICU-cohort: Risk Factors of Critical Care Admission and Intensive Care Mortality	NA	https://ClinicalTrials.gov/show/NCT04390074	NCT04390074	Sweden	SWE	Observational	9905	NA	Chronic medications as risk factor of intensive care for COVID-19|Comorbidities as risk factor of intensive care for COVID-19|Chronic medications as risk factor of death during intensive care for COVID-19|Comorbidities as risk factor of death during intensive care for COVID-19	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Survival and 30-days Hospital Outcome in COVID-19 Patients in Upper Egypt	https://doi.org/10.1101/2020.08.26.20180992	https://ClinicalTrials.gov/show/NCT04488588	NCT04488588	Egypt	EGY	Observational	1964	NA	Number of co-morbidities in hospitalized patients with COVID-19|Causes of ICU admission	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Evolution of Pulmonary Ultrasound in Patients Hospitalized for Covid (Coronavirus Disease) 19	NA	https://ClinicalTrials.gov/show/NCT04341766	NCT04341766	France	FRA	Observational	106	NA	Characteristics of pulmonary ultrasound for Covid-19 patients|ChaRateristics of pulmonary CT-scan for Covid-19 patients	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Case Fatalities in Hospitalised COVID-19 Patients in the UK	NA	https://ClinicalTrials.gov/show/NCT04527458	NCT04527458	UK	GBR	Observational	70000	NA	Case fatality	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICU	https://doi.org/10.1111/aas.13694	https://ClinicalTrials.gov/show/NCT04378582	NCT04378582	Brazil	BRA	Observational	1589	NA	ICU survival at 28 days|Hospital survival at 60 days|Duration of mechanical ventilation|Need for renal replacement therapy|Complications during the ICU stay	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Therapeutic Plasma Exchange for Coronavirus Disease-2019 Triggered Cytokine Release Storm|(PLEX)	https://doi.org/10.1371/journal.pone.0244853	https://ClinicalTrials.gov/show/NCT04485169	NCT04485169	Pakistan	PAK	Interventional	280	NA	Survival|Duration of hospitalization|Timing of PCR negativity|Time to CRS resolution|Complications	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19	https://doi.org/10.1714/3343.33127	https://ClinicalTrials.gov/show/NCT04318418	NCT04318418	Italy	ITA	Observational	3400	NA	Severe COVID-19|Death	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
A Single-center Retrospective Study to Find Prediction Factors Related to Mortality of COVID-19 Patients.	NA	https://ClinicalTrials.gov/show/NCT04365634	NCT04365634	China	CHN	Observational	306	NA	Demographic|Clinical|Laboratory|Imaging|Drugs|Comorbidities	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Hypertension in Patients Hospitalized With COVID-19	https://doi.org/10.1536/ihj.20-323	https://ClinicalTrials.gov/show/NCT04318301	NCT04318301	China	CHN	Observational	275	NA	Rate of Death|Severity of pneumonia	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Characteristics and Outcomes of Hospitalized Patients With COVID-19 in Spain	NA	https://ClinicalTrials.gov/show/NCT04355871	NCT04355871	Spain	ESP	Observational	4035	NA	Mechanical ventilation	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Prevalence and Characteristics of Pulmonary Embolism on COVID-19 Patients Presenting Respiratory Symptoms	https://doi.org/10.1016/j.thromres.2020.11.001	https://ClinicalTrials.gov/show/NCT04420312	NCT04420312	France	FRA	Observational	1024	NA	Clinical|Imaging 	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HYPONATREMIA IN COVID-19 PATIENTS	NA	https://ClinicalTrials.gov/show/NCT04493268	NCT04493268	Argentina	ARG	Observational	250	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mortality|ICU 	NA
Prognostic Factors of Patients With COVID-19	NA	https://ClinicalTrials.gov/show/NCT04292964	NCT04292964	China	CHN	Observational	201	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mortality|Severe state	NA
Early Risk Stratification of Patient Hospitalized for SARS-CoV2 Infection: Critical COVID-19 France CCF	https://doi.org/10.1093/cid/ciaa601	https://ClinicalTrials.gov/show/NCT04344327	NCT04344327	France	FRA	Observational	2878	NA	Death Rate|ICU|Ventilation analysis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Obesity and Mortality of Critically Ill Patients With COVID-19	NA	https://ClinicalTrials.gov/show/NCT04425213	NCT04425213	France	FRA	Observational	250	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ICU|Mortality|Invasive mechanical ventilation 	NA